Trulicity Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Trulicity is a prescription medication containing the active ingredient dulaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist. It is used to improve blood sugar control in adults with type 2 diabetes, often in combination with other medications. Administered as a once-weekly injection, it may also support weight loss and reduce the risk of cardiovascular events.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types of trulicity are the prefilled syringe package and the vial package. A prefilled syringe package is a medical container that holds a single dose of the medication, pre-filled by the manufacturer. This ensures precise dosing, minimizes contamination risk, and provides convenience for both healthcare providers and patients. It is used in managing type 2 diabetes, glycemic control, weight management, and reducing cardiovascular risks, and is distributed through hospital pharmacies, retail pharmacies, and online platforms.

The trulicity market research report is one of a series of new reports from The Business Research Company that provides trulicity market statistics, including the trulicity industry's global market size, regional shares, competitors with a trulicity market share, detailed trulicity market segments, market trends and opportunities, and any further data you may need to thrive in the trulicity industry. This trulicity market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The trulicity market size is expected to see strong growth in the next few years. It will grow to $11,180 million in 2029 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to raising adoption of digital health technologies, raising health awareness among people, increasing educational and awareness programs, growing demand for innovative therapies, increasing access to healthcare activities. Major trends in the forecast period include technological integration, strategic collaboration, product innovation, focus on personalized medicines, combination therapies, sustainable initiatives.

The increasing diabetes population is expected to significantly propel the growth of the trulicity market. Diabetes, a chronic condition characterized by high blood sugar levels due to the body's inability to produce or use insulin effectively, is rising due to factors such as urbanization, unhealthy diets, physical inactivity, and genetic predisposition. The growing prevalence of diabetes is increasing the demand for effective treatments, including Trulicity, which helps manage blood sugar levels and improves patient outcomes. For instance, in March 2024, the Office for Health Improvement and Disparities reported that the percentage of people with type 1 diabetes receiving comprehensive care in England increased from 35.2% in 2022 to 43.8% in 2023. This reflects a rising focus on managing diabetes and underscores the market potential for trulicity.

A key trend in the trulicity market is the development of innovative formulations to reduce the risk of major adverse cardiovascular events. Trulicity is a once-weekly injectable medication that mimics the action of GLP-1, enhancing insulin secretion, slowing gastric emptying, and reducing appetite, which helps improve blood sugar management. In November 2022, Eli Lilly and Company, a US-based pharmaceutical company, received FDA approval for Trulicity as an adjunct to diet and exercise for improving glycemic control in adults and pediatric patients aged 10 and older with type 2 diabetes mellitus (T2DM). This approval followed a successful clinical trial demonstrating its effectiveness in reducing cardiovascular risks in diabetes patients.

A significant trend in the trulicity market is the focus on expanding biologics production facilities to meet rising demand and gain a competitive advantage. Biologics production facilities are specialized plants designed to manufacture complex biologic drugs, such as monoclonal antibodies, vaccines, and cell and gene therapies, which require advanced manufacturing processes. For instance, Eli Lilly and Company, a major player in the market, has committed to substantial investments to enhance its manufacturing capacity. In January 2023, Lilly invested $450 million to expand its North Carolina plant, boosting production of Trulicity, its diabetes treatment. This expansion is part of a broader $1.7 billion investment in the facility, with full production expected to begin in 2027. Additionally, Lilly is constructing two new facilities in Indiana and investing €400 million in biologics production in Ireland. These moves reflect the company's strategy to support growing demand for its products and ensure continued innovation in biologics manufacturing.

Major players operating in the trulicity market are Eli Lilly And Company and Novo Nordisk.

North America was the largest region in the trulicity market in 2024. The regions covered in trulicity report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the trulicity market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The trulicity market consists of sales of trulicity (Dulaglutide) injection, trulicity 3 mg and 4.5 mg, and trulicity (Dulaglutide) 0.75 mg and 1.5 mg. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Trulicity Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on trulicity market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for trulicity ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The trulicity market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Prefilled Syringe Package; Vial Package
• 2) By Application: Type 2 Diabetes Management; Glycemic Control; Weight Management; Cardiovascular Risk Reduction
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Companies Mentioned: Eli Lilly And Company; Novo Nordisk
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.